Quality of life and functional recovery after venous stent placement for postthrombotic syndrome: insights from the ARIVA multinational randomized trial
Rattachement africain : de, ch, nl, at. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Postthrombotic syndrome (PTS) is a disabling complication of deep vein thrombosis and is associated with impaired functional status. Objectives: To assess the impact of stent placement for post-thrombotic syndrome on functional outcomes and quality of life. Methods: The Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients with Postthrombotic Syndrome trial was a multinational, randomized study comparing rivaroxaban plus aspirin vs rivaroxaban monotherapy after venous revascularization for PTS. The Villalta score and the Chronic Venous Insufficiency Quality of Life Questionnaire-20 (CIVIQ-20) were assessed at randomization and during 6-month follow-up. A multivariable mixed-effects model was used to identify predictors of quality of life (QoL). Results: Of 149 enrolled patients, 55% had moderate-to-severe PTS at baseline, according to the Villalta score. Compared with patients with mild PTS, they were characterized by longer stent segments, higher body mass index, and were more frequently smokers. The 6-month primary patency rate was similar between groups: 91.5% vs 95.5%, respectively. The improvement in PTS severity consisted of an overall mean reduction of -6.5 (SD 4.6) points, corresponding to a change of -8.5 (5.0) points among patients with moderate-to-severe PTS and -4 (2.6) points among patients with mild PTS after 6 months. Median CIVIQ-20 scores were lower, indicating worse QoL, among patients with moderate-to-severe PTS compared with mild PTS, consistently at baseline and all follow-up timepoints. Female sex and greater PTS severity were independently associated with worse QoL after adjustment for age, body mass index, treatment group, adverse events, and timepoint. Conclusion: Over the 6 months after endovascular treatment accessory to standard care for PTS, both PTS severity measured by the Villalta score and QoL measured by CIVIQ-20 improved. However, greater PTS severity and female sex were independently associated with worse QoL outcomes.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Quality of life and functional recovery after venous stent placement for postthrombotic syndrome: insights from the ARIVA multinational randomized trial
- Date Crossref
- 01/07/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Johannes Gutenberg University Mainz Center for Thrombosis and Hemostasis pays non établi dans la noticeUniversité ou école supérieure
-
University Medical Center of the Johannes Gutenberg University Mainz pays non établi dans la noticeÉtablissement de santé
-
University Hospital Zurich Department of Vascular Medicine pays non établi dans la noticeÉtablissement de santé
-
Leiden University Medical Center Department of Medicine - Thrombosis and Hemostasis pays non établi dans la noticeOrganisme public
-
Heidelberg University Department of Cardiology pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Heidelberg pays non établi dans la noticeÉtablissement de santé
-
Universitätsklinikum Aachen pays non établi dans la noticeÉtablissement de santé
-
Medical University of Vienna Department of Medicine II pays non établi dans la noticeUniversité ou école supérieure
-
Rhineland-Westphalian Technical University Clinic of Vascular and Endovascular Surgery pays non établi dans la noticeUniversité ou école supérieure
Center for Thrombosis and Hemostasis — Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz et Department of Vascular Medicine — University Hospital Zurich, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.